Abate As Indust

{
  "main_header": {
    "sid": 453222,
    "name": "Abate As Indust",
    "stock_name": "Abate As Indust",
    "full_name": "Abate As Industries Ltd",
    "name_url": "stocks-analysis/abate-as-indust",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "11.25",
    "chg": -0.34,
    "chgp": "-2.93%",
    "dir": -1,
    "prev_price": "11.59",
    "mcapval": "188.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531658,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE454E01013",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "12.14 k",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abate-as-indust-453222-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Abate As Industries Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abate-as-industries-ltd-upgraded-to-sell-on-technical-improvements-despite-fundamental-challenges-3899837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbateAsIndustri_mojoScore_3899837.png",
        "date": "2026-03-19 08:09:48",
        "description": "Abate As Industries Ltd, a micro-cap player in the hospital sector, has seen its investment rating upgraded from Strong Sell to Sell as of 18 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting a reassessment of its risk and return profile by analysts."
      },
      {
        "title": "Abate As Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abate-as-industries-ltd-is-rated-strong-sell-3886578",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbateAsIndustri_mojoScore_3886578.png",
        "date": "2026-03-12 10:10:52",
        "description": "Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Abate As Industries Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abate-as-industries-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3854826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AbateAsIndustri_mojoScore_3854826.png",
        "date": "2026-02-25 08:11:14",
        "description": "Abate As Industries Ltd, a player in the hospital sector, has seen its investment rating downgraded from Sell to Strong Sell as of 24 February 2026, reflecting deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamentals despite recent positive quarterly financial results."
      },
      {
        "title": "Abate As Industries Ltd Upgraded to Sell on Improved Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abate-as-industries-ltd-upgraded-to-sell-on-improved-financial-and-technical-metrics-3843751",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AbateAsIndustri_mojoScore_3843751.png",
        "date": "2026-02-17 08:29:01",
        "description": "Abate As Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting significant improvements in its financial performance and technical outlook. Despite lingering concerns over valuation and long-term fundamentals, the company’s recent quarterly results and market behaviour have prompted a reassessment of its prospects."
      },
      {
        "title": "Abate As Industries Ltd Surges 27.28%: Quarterly Results and Market Volatility Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abate-as-industries-ltd-surges-2728-quarterly-results-and-market-volatility-shape-week-3840121",
        "imagepath": "",
        "date": "2026-02-14 17:08:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 9:</strong> Stock opens strong at Rs.11.39, up 4.98%</p>\n                    <p><strong>Feb 10:</strong> Continued gains with Rs.11.95 close (+4.92%) on heavy volume</p>\n                    <p><strong>Feb 11:</strong> Price rises to Rs.12.54 (+4.94%) amid steady market</p>\n                    <p><strong>Feb 12:</strong> Stock climbs to Rs.13.16 (+4.94%) despite Sensex dip</p>\n                    <p><strong>Feb 13:</strong> Reports very positive quarterly results; closes at Rs.13.81 (+4.94%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n             ..."
      },
      {
        "title": "Are Abate As Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-abate-as-industries-ltd-latest-results-good-or-bad-3838211",
        "imagepath": "",
        "date": "2026-02-13 19:57:23",
        "description": "Abate As Industries Ltd's latest financial results for Q3 FY26 present a mixed picture of operational performance. The company reported net sales of ₹42.69 crores, reflecting a modest sequential growth of 1.33% from ₹42.13 crores in Q2 FY26. This growth, while positive, is a significant deceleration compared to the explosive 191.41% increase seen between Q1 and Q2 FY26. \n\nIn terms of profitability, the net profit for Q3 FY26 was ₹3.06 crores, which represents a sequential decline of 24.82% from the previous quarter's profit of ₹4.07 crores. This decline, however, must be viewed in the context of the extraordinary growth in Q2, where profits surged by 80.89%. The operating margin for the latest quarter stood at 9.23%, marking an improvement from 9.14% in Q2 FY26, indicating enhanced operational efficiency.\n\nDespite these operational achievements, the company faces challenges, particularly concerning its retu..."
      },
      {
        "title": "Abate As Industries Ltd Reports Very Positive Quarterly Financial Performance Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abate-as-industries-ltd-reports-very-positive-quarterly-financial-performance-amid-market-volatility-3837402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AbateAsIndustri_fintrenddot_3837402.png",
        "date": "2026-02-13 11:00:25",
        "description": "Abate As Industries Ltd, a key player in the hospital sector, has demonstrated a marked improvement in its financial performance for the quarter ended December 2025. The company’s latest results reveal record-high net sales and operating profits, signalling a significant turnaround in its financial trend and offering a fresh perspective for investors amid a challenging market backdrop."
      },
      {
        "title": "Abate As Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abate-as-industries-ltd-is-rated-strong-sell-3837017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AbateAsIndustri_mojoScore_3837017.png",
        "date": "2026-02-13 10:11:08",
        "description": "Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Abate As Industries Q3 FY26: Remarkable Turnaround Marred by Extreme Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/abate-as-industries-q3-fy26-remarkable-turnaround-marred-by-extreme-valuation-concerns-3837700",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AbateAsIndustri_quaterlyResult_3837700.png",
        "date": "2026-02-13 09:28:25",
        "description": "Abate As Industries Limited, a micro-cap hospital sector player with a market capitalisation of ₹218.00 crores, has delivered a stunning operational turnaround in Q3 FY26, posting consolidated net profit of ₹3.06 crores—a dramatic reversal from losses in the previous year. However, this impressive operational performance is overshadowed by a troubling valuation picture, with the stock trading at an eye-watering 189x trailing earnings and earning a \"STRONG SELL\" rating with a score of just 27 out of 100."
      }
    ],
    "total": 171,
    "sid": "453222",
    "stock_news_url": "https://www.marketsmojo.com/news/abate-as-industries-453222"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 7(2) Of The SEBI (PIT) Regulations 2015 As Received From Al Salama Eye Research Foundation",
      "datetime": "10-Mar-2026",
      "details": "Disclosure under Regulation 7(2) of SEBI (PIT) Regulations 2015 as received from Al Salama Eye Research Foundation",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015",
      "datetime": "02-Mar-2026",
      "details": "Disclosure under Regulation 7(2) of the PIT Regulations 2015 as received from Al Salama Eye Research Foundation (Promoter Group)",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30- Launch Of AbateS Indigenous EMR & Integrated Eye Hospital Clinic Management System",
      "datetime": "17-Feb-2026",
      "details": "Announcement under Regulation 30- Launch of Abates Indigenous EMR & Clinical Management System",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Abate As Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 31 Jul 25",
          "dt": "2025-07-31",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Abate As Industries Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges

2026-03-19 08:09:48

Abate As Industries Ltd, a micro-cap player in the hospital sector, has seen its investment rating upgraded from Strong Sell to Sell as of 18 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting a reassessment of its risk and return profile by analysts.

Read full news article

Abate As Industries Ltd is Rated Strong Sell

2026-03-12 10:10:52

Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with the latest comprehensive analysis.

Read full news article

Abate As Industries Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-02-25 08:11:14

Abate As Industries Ltd, a player in the hospital sector, has seen its investment rating downgraded from Sell to Strong Sell as of 24 February 2026, reflecting deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamentals despite recent positive quarterly financial results.

Read full news article

Abate As Industries Ltd Upgraded to Sell on Improved Financial and Technical Metrics

2026-02-17 08:29:01

Abate As Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting significant improvements in its financial performance and technical outlook. Despite lingering concerns over valuation and long-term fundamentals, the company’s recent quarterly results and market behaviour have prompted a reassessment of its prospects.

Read full news article

Abate As Industries Ltd Surges 27.28%: Quarterly Results and Market Volatility Shape Week

2026-02-14 17:08:49

Key Events This Week

Feb 9: Stock opens strong at Rs.11.39, up 4.98%

Feb 10: Continued gains with Rs.11.95 close (+4.92%) on heavy volume

Feb 11: Price rises to Rs.12.54 (+4.94%) amid steady market

Feb 12: Stock climbs to Rs.13.16 (+4.94%) despite Sensex dip

Feb 13: Reports very positive quarterly results; closes at Rs.13.81 (+4.94%)

Week Open

...

Read full news article

Are Abate As Industries Ltd latest results good or bad?

2026-02-13 19:57:23

Abate As Industries Ltd's latest financial results for Q3 FY26 present a mixed picture of operational performance. The company reported net sales of ₹42.69 crores, reflecting a modest sequential growth of 1.33% from ₹42.13 crores in Q2 FY26. This growth, while positive, is a significant deceleration compared to the explosive 191.41% increase seen between Q1 and Q2 FY26. In terms of profitability, the net profit for Q3 FY26 was ₹3.06 crores, which represents a sequential decline of 24.82% from the previous quarter's profit of ₹4.07 crores. This decline, however, must be viewed in the context of the extraordinary growth in Q2, where profits surged by 80.89%. The operating margin for the latest quarter stood at 9.23%, marking an improvement from 9.14% in Q2 FY26, indicating enhanced operational efficiency. Despite these operational achievements, the company faces challenges, particularly concerning its retu...

Read full news article

Abate As Industries Ltd Reports Very Positive Quarterly Financial Performance Amid Market Volatility

2026-02-13 11:00:25

Abate As Industries Ltd, a key player in the hospital sector, has demonstrated a marked improvement in its financial performance for the quarter ended December 2025. The company’s latest results reveal record-high net sales and operating profits, signalling a significant turnaround in its financial trend and offering a fresh perspective for investors amid a challenging market backdrop.

Read full news article

Abate As Industries Ltd is Rated Strong Sell

2026-02-13 10:11:08

Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Abate As Industries Q3 FY26: Remarkable Turnaround Marred by Extreme Valuation Concerns

2026-02-13 09:28:25

Abate As Industries Limited, a micro-cap hospital sector player with a market capitalisation of ₹218.00 crores, has delivered a stunning operational turnaround in Q3 FY26, posting consolidated net profit of ₹3.06 crores—a dramatic reversal from losses in the previous year. However, this impressive operational performance is overshadowed by a troubling valuation picture, with the stock trading at an eye-watering 189x trailing earnings and earning a "STRONG SELL" rating with a score of just 27 out of 100.

Read full news article

View All News